164 related articles for article (PubMed ID: 9250553)
1. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
McCollam PL; Crouch MA; Watson JE
Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-acid glycoprotein concentrations and cerebrospinal fluid drug distribution after subarachnoid hemorrhage.
Woodward DK; Hatton J; Ensom MH; Young B; Dempsey R; Clifton GD
Pharmacotherapy; 1998; 18(5):1062-8. PubMed ID: 9758316
[TBL] [Abstract][Full Text] [Related]
3. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
4. Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation.
Kirpizidis C; Stavrati A; Geleris P; Boudoulas H
J Cardiol; 2001 Dec; 38(6):351-4. PubMed ID: 11806093
[TBL] [Abstract][Full Text] [Related]
5. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
6. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
Kishino S; Nomura A; Itoh S; Nakagawa T; Takekuma Y; Sugawara M; Furukawa H; Todo S; Miyazaki K
Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
Bellandi F; Dabizzi RP; Mugnaioni G; Cantini F; Palchetti R
G Ital Cardiol; 1997 Oct; 27(10):1029-35. PubMed ID: 9410773
[TBL] [Abstract][Full Text] [Related]
8. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
[TBL] [Abstract][Full Text] [Related]
9. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
12. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
Kays MB; White RL; Gatti G; Gambertoglio JG
Pharmacotherapy; 1992; 12(1):50-5. PubMed ID: 1549539
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
[TBL] [Abstract][Full Text] [Related]
15. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
17. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
[TBL] [Abstract][Full Text] [Related]
19. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
